Skip to main content

Articles

Page 3 of 337

  1. Primary cervical cancer screening and treating precancerous lesions are effective ways to prevent cervical cancer. However, the coverage rates of human papillomavirus (HPV) vaccines and routine screening are l...

    Authors: Wen Yang, Xiangshu Jin, Liying Huang, Shufang Jiang, Jia Xu, Yurong Fu, Yaoyao Song, Xueyan Wang, Xueqing Wang, Zhiming Yang and Yuanguang Meng
    Citation: BMC Cancer 2024 24:776
  2. Lung cancer (LC), characterized by high incidence and mortality rates, presents a significant challenge in oncology. Despite advancements in treatments, early detection remains crucial for improving patient ou...

    Authors: Xianzhe Fan, Ran Zhong, Hengrui Liang, Qiu Zhong, Hongtai Huang, Juan He, Yang Chen, Zixun Wang, Songlin Xie, Yu Jiang, Yuechun Lin, Sitong Chen, Wenhua Liang and Jianxing He
    Citation: BMC Cancer 2024 24:775
  3. Ubiquitin-specific peptidase 10 (USP10), a typical de-ubiquitinase, has been found to play a double-edged role in human cancers. Previously, we reported that the expression of USP10 was negatively correlated w...

    Authors: Zhi Zeng, Yina Li, Heng Zhou, Mingyang Li, Juan Ye, Dan Li, Yuxi Zhu, Yonggang Zhang, Xu Zhang, Yunchao Deng, Juan Li, Lijuan Gu and Jie Wu
    Citation: BMC Cancer 2024 24:773
  4. Despite the existence of numerous studies investigating the diagnostic potential of blood microRNAs for colorectal cancer, the microRNAs under consideration vary widely, and comparative analysis of their diagn...

    Authors: Jianhao Xu, Lanfen Pan, Dan Wu, Liqian Yao, Wenqian Jiang, Jiarui Min, Song Xu and Zhiyong Deng
    Citation: BMC Cancer 2024 24:770
  5. Accumulating evidence indicates that the use of antibiotics (ATBs) in cancer patients is potentially correlated with patient prognosis. Interestingly, the use of these agents is not uncommon in colorectal canc...

    Authors: Mingyue Xu, Yuanyuan Chen, Panhua Li, Qianwen Ye, Shouhan Feng and Bing Yan
    Citation: BMC Cancer 2024 24:769
  6. Pancreatic ductal adenocarcinoma (PDAC) is a ‘difficult-to-treat’ entity. To forecast its prognosis, we introduced a new biomarker, SARIFA (stroma areactive invasion front areas), which are areas at the tumour...

    Authors: Przemyslaw Grochowski, Bianca Grosser, Florian Sommer, Andreas Probst, Johanna Waidhauser, Gerhard Schenkirsch, Nic G. Reitsam and Bruno Märkl
    Citation: BMC Cancer 2024 24:768
  7. Breast cancer (BrCa) is a predominant malignancy, with metastasis occurring in one in eight patients, nearly half of which target the bone, leading to serious complications such as pain, fractures, and comprom...

    Authors: Michael S. Bohanske, Kaveh Momenzadeh, Peer van der Zwaal, Frederik J.H. Hoogwater, Esther Cory, Peter Biggane, Brian D. Snyder and Ara Nazarian
    Citation: BMC Cancer 2024 24:767
  8. In oral squamous cell carcinoma (OSCC), the tumor-node-metastasis (TNM) staging system is a significant factor that influences prognosis and treatment decisions for OSCC patients. Unfortunately, TNM staging do...

    Authors: Wattawan Wongpattaraworakul, Allen Choi, Marisa R. Buchakjian, Emily A. Lanzel, Anand Rajan KD and Andrean L. Simons
    Citation: BMC Cancer 2024 24:766
  9. It is unclear whether hepatectomy, which ranges in invasiveness from partial to major hepatectomy, is safe and feasible for older adult patients. Therefore, we compared its postoperative complications and long...

    Authors: Hiroki Kanno, Kazuaki Hashimoto, Hisamune Sakai, Toshiro Ogata, Shogo Fukutomi, Masanori Akashi, Yuichi Goto, Takeshi Aoyagi, Masahiko Taniguchi and Toru Hisaka
    Citation: BMC Cancer 2024 24:765
  10. Clinically significant portal hypertension (CSPH) seriously affects the feasibility and safety of surgical treatment for hepatocellular carcinoma (HCC) patients. The aim of this study was to establish a new su...

    Authors: Jia-zhou Ye, Hua-ze Lu, Can Zeng, Guo Lei, Xiao-bo Wang, Jie Chen, Tao Bai, Fei-xiang Wu, Rong-yun Mai, Wei-xing Guo and Le-qun Li
    Citation: BMC Cancer 2024 24:764
  11. Cancer is among the leading cause of death worldwide. Chemotherapy is commonly used in cancer management and among the challenges in managing cancer patients is renal insufficiency (RI), which can be due to ca...

    Authors: Hamidu N. Rajabu, Sven Gudmund Hinderaker, Penina Mnandi and Ritah F. Mutagonda
    Citation: BMC Cancer 2024 24:763
  12. Despite evidence supporting the high correlation of the novel platelet-to-albumin ratio (PAR) with survival in diverse malignancies, its prognostic relevance in nasopharyngeal carcinoma (NPC) remains underexpl...

    Authors: Xin Hua, Fei Xu, Wei Shi, Zhi-Qing Long, Xin Huang, Fang-Fang Duan, Si-Fen Wang, Chao Zhang, Meng-Di Wang, Wei-Qiong Ni, Wen Xia, Jia-Yi Chen and Yun-Sheng Gao
    Citation: BMC Cancer 2024 24:762
  13. High-grade B-cell lymphoma (HGBCL), the subtype of non-Hodgkin lymphoma, to be relapsed or refractory in patients after initial therapy or salvage chemotherapy. Dual dysregulation of MYC and BCL2 is one of the...

    Authors: Lin Liu, Wenbin Mo, Miao Chen, Yi Qu, Pingping Wang, Ying Liang and Xiaojing Yan
    Citation: BMC Cancer 2024 24:761
  14. Psychosocial factors and socioeconomic status have been associated with incidence, survival, and quality of life among patients with head and neck cancer. We investigated the association between different psyc...

    Authors: Markus Atula, Timo Atula, Katri Aro, Heikki Irjala, Elina Halme, Anna Jouppila-Mättö, Petri Koivunen, Tommy Wilkman, Antti Mäkitie, Marko Elovainio and Laura Pulkki-Råback
    Citation: BMC Cancer 2024 24:760
  15. Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide. Inhibitor of kappa B kinase interacting protein (IKBIP) has been reported to promote glioma progression, but its role in o...

    Authors: Jiannan Hu, Chuanjing Dai, Zhaoji Ding, Yixiao Pan, Lingxiao Lu, Jiaqian Bao and Jingmin Zheng
    Citation: BMC Cancer 2024 24:759
  16. Nowadays, different therapeutic options are available for the first-line treatment of metastatic renal cell carcinoma (mRCC). Immuno-combinations are the standard first-line therapy in all mRCC patients regard...

    Authors: Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso and Davide Bimbatti
    Citation: BMC Cancer 2024 24:757
  17. Anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF) or immune checkpoint inhibitors (ICIs) combined with chemotherapy are commonly administered to cancer patients. Although cancer patients ...

    Authors: Jianfen Zhu, Xiaokai Ding, Jianna Zhang, Bo Chen, Xiaohan You, Xinxin Chen and Tianxin Chen
    Citation: BMC Cancer 2024 24:756
  18. Diffuse midline glioma (DMG), H3 K27M-mutant is a type of diffuse high-grade glioma that occurs in the brain midline carrying an extremely poor prognosis under the best efforts of surgery, radiation, and other...

    Authors: Yu-An Li, Chuan Zhao, Jing-Jing Ge, Cheng Li, Feng-Jun Xue, Shao-Pei Qi, Chi Zhao, Chen-Chen Kong and Jun-Ping Zhang
    Citation: BMC Cancer 2024 24:754

    The Correction to this article has been published in BMC Cancer 2024 24:829

  19. Investigating novel therapeutic strategies for colorectal cancer (CRC) is imperative. However, there is limited research on the use of drugs to target peripheral blood immune cells in this context. To address ...

    Authors: Runze Huang, Xin Jin, Ziting Jiang, Yixiu Wang, Yibin Wu, Lu Wang and Weiping Zhu
    Citation: BMC Cancer 2024 24:753
  20. Among gynaecological malignancies, endometrial cancer (EC) is the most prevalent type of uterine cancer affecting women. This study explored the proteomic profiles of plasma samples obtained from EC patients, ...

    Authors: Khalid Akkour, Ibrahim O Alanazi, Assim A Alfadda, Afshan Masood, Hani Alhalal, Salini Scaria Joy, Ali Bassi, Eman Alshehri, Moudi A Alwehaibi, Maria Arafah and Hicham Benabdelkamel
    Citation: BMC Cancer 2024 24:752
  21. Despite the availability of effective vaccines, human papillomavirus (HPV) vaccine uptake remains low in most resource-limited settings including Nigeria. Mobile health technology (mHealth) has the potential t...

    Authors: Kehinde S. Okunade, Adebola A. Adejimi, Temitope V. Adekanye, Matthew J. Allsop, Hameed Adelabu, Olufemi Thomas-Ogodo, Tonia C. Onyeka, Teniola Lawanson, Godwin O. Akaba, Omolola Salako, Rose I. Anorlu and Jonathan S. Berek
    Citation: BMC Cancer 2024 24:751
  22. To explore challenges of liquid-based cytology (LBC) specimens for next-generation sequencing (NGS) in lung adenocarcinoma and evaluate the efficacy of targeted therapy.

    Authors: Xiaoyue Xiao, ZiHan Sun, Shuo Liang, Weihua Li, HuiQin Guo, Huan Zhao, LinLin Zhao, HaiYue Ma, Yue Sun, Cong Wang, XinXiang Chang and ZhiHui Zhang
    Citation: BMC Cancer 2024 24:749
  23. Thymic epithelial tumors (TETs) are rare neoplasms often associated with immune-related disorders. Patients with Good’s syndrome (GS), an adult-acquired TET-related immunodeficiency, are at a high risk of mort...

    Authors: Erica Pietroluongo, Annarita Peddio, Pietro De Placido, Marianna Tortora, Margaret Ottaviano, Monica Gelzo, Gustavo Cernera, Maria Foggia, Antonio Riccardo Buonomo, Biagio Pinchera, Emanuela Zappulo, Simona Mercinelli, Letizia Cattaneo, Alessia Sardanelli, Giulio Viceconte, Riccardo Scotto…
    Citation: BMC Cancer 2024 24:748
  24. The prognosis of patients with Relapsed/Refractory Osteosarcoma (R/R OS) remains dismal without an agreement on systemic therapy. The use of High-Dose Ifosfamide (14 g/sqm) with an external pump in outpatient ...

    Authors: Elisa Tirtei, Anna Campello, Veronica Sciannameo, Sebastian Dorin Asaftei, Cristina Meazza, Giovanna Sironi, Alessandra Longhi, Toni Ibrahim, Angela Tamburini, Luca Coccoli, Fanj Crocco, Celeste Cagnazzo, Elvira De Luna, Paola Quarello, Paola Berchialla and Franca Fagioli
    Citation: BMC Cancer 2024 24:747
  25. Basement membrane (BM) is an important component of the extracellular matrix, which plays an important role in the growth and metastasis of tumor cells. However, few biomarkers based on BM have been developed ...

    Authors: Xuezhou Zhang, Baoan Hong, Hongwei Li, Jiahui Zhao, Mingchuan Li, Dechao Wei, Yongxing Wang and Ning Zhang
    Citation: BMC Cancer 2024 24:746
  26. As gastric cancer patients aged ≥ 85 years have a short life expectancy and often die from other diseases such as pneumonia, indications for surgery are controversial. In this study, we retrospectively analyze...

    Authors: Shunji Endo, Masaharu Higashida, Kei Furuya, Shuya Yano, Toshimasa Okada, Kazuhiko Yoshimatsu, Yoshinori Fujiwara and Tomio Ueno
    Citation: BMC Cancer 2024 24:745
  27. Tumor hypoxia is associated with prostate cancer (PCa) treatment resistance and poor prognosis. Pimonidazole (PIMO) is an investigational hypoxia probe used in clinical trials. A better understanding of the cl...

    Authors: Xinpei Ci, Sujun Chen, Rui Zhu, Mojgan Zarif, Rahi Jain, Wangyuan Guo, Matthew Ramotar, Linsey Gong, Wenjie Xu, Olivia Singh, Sheila Mansouri, Gelareh Zadeh, Gong-Hong Wei, Wei Xu, Robert Bristow, Alejandro Berlin…
    Citation: BMC Cancer 2024 24:744
  28. Breast cancer is a prevalent cancer characterized by its aggressive nature and potential to cause mortality among women. The rising mortality rates and women’s inadequate perception of the disease’s severity i...

    Authors: Sepideh Mashayekh-Amiri, Mohammad Asghari Jafarabadi, Mina Hosseinzadeh, Elham seyed Kanani and Mojgan Mirghafourvand
    Citation: BMC Cancer 2024 24:743
  29. Nasopharyngeal adenoid cystic carcinoma (NACC) is a relatively rare salivary gland tumor that is generally associated with poor outcomes. High-dose radiotherapy is a key treatment for patients with NACC. This ...

    Authors: Weixu Hu, Jiyi Hu, Qingting Huang, Jing Gao, Haojiong Zhang and Lin Kong
    Citation: BMC Cancer 2024 24:742
  30. Sarcopenia is characterized by reduced skeletal muscle volume and is a condition that is prevalent among elderly patients and associated with poor prognosis as a comorbidity in malignancies. Given the aging po...

    Authors: Makoto Takahashi, Kazuhiro Sakamoto, Yosuke Kogure, Shuko Nojiri, Yuki Tsuchiya, Kumpei Honjo, Masaya Kawai, Shun Ishiyama, Kiichi Sugimoto, Kunihiko Nagakari and Yuichi Tomiki
    Citation: BMC Cancer 2024 24:741
  31. Using the preoperative pan-immune-inflammation value (PIV) and the monocyte to high-density lipoprotein ratio (MHR) to reflect inflammation, immunity, and cholesterol metabolism, we aim to develop and visualiz...

    Authors: Qinghua Liu, Haohao Wang, Qingjie Chen, Ruiying Luo and Changjiang Luo
    Citation: BMC Cancer 2024 24:740
  32. A growing number of expression quantitative trait loci (eQTLs) have been found to be linked with tumorigenesis. In this article, we employed integrated Mendelian randomization (MR) analyses to identify novel s...

    Authors: Qiming Wang, Shaopeng Chen, Gang Wang, Tielong Zhang and Yulong Gao
    Citation: BMC Cancer 2024 24:739
  33. Bladder cancer (BC) is among the most prevalent malignant urothelial tumors globally, yet the prognosis for patients with muscle-invasive bladder cancer (MIBC) remains dismal, with a very poor 5-year survival ...

    Authors: Hao Meng, Rui Yang, Qianqian Lin, Wenqi Du, Zheng Chu, Yaxin Cao, Mengxiang Du, Yazhen Zhao, Jiheng Xu, Ziyi Yang, Xiaomin Xie, Lijiong He and Chuanshu Huang
    Citation: BMC Cancer 2024 24:737
  34. Glioblastoma (GBM) is the most common and aggressive primary brain cancer. The treatment of GBM consists of a combination of surgery and subsequent oncological therapy, i.e., radiotherapy, chemotherapy, or the...

    Authors: Radek Lakomý, Martina Lojová, Lenka Souckova, Ludmila Hynkova, Katerina Polachova, Jiri Vasina, Regina Demlová, Alexandr Poprach, Jiri Sana, Tomas Prochazka, Martin Smrcka, Pavel Fadrus, Radim Jancalek, Iveta Selingerova, Renata Belanova, Pavel Slampa…
    Citation: BMC Cancer 2024 24:736
  35. The addition of pertuzumab (P) to trastuzumab (H) and standard chemotherapy (CT) as neoadjuvant treatment (NaT) for patients with HER2 + breast cancer (BC), has shown to increase the pathological complete resp...

    Authors: Fabio Canino, Monica Barbolini, Ugo De Giorgi, Tommaso Fontana, Valeria Gaspari, Caterina Gianni, Lorenzo Gianni, Antonio Maestri, Santino Minichillo, Luca Moscetti, Antonella Mura, Stefania Vittoria Luisa Nicoletti, Claudia Omarini, Rachele Pagani, Samanta Sarti, Angela Toss…
    Citation: BMC Cancer 2024 24:735
  36. The role of familial influence in chronic myeloid leukaemia (CML) occurrence is less defined. Previously, we conducted a study to determine the prevalence of harbouring BCR::ABL1 in our local adult normal populat...

    Authors: Jew Win Kuan, Anselm Ting Su, Sai-Peng Sim and Siow Phing Tay
    Citation: BMC Cancer 2024 24:734
  37. Checkpoint inhibitors (CPIs) are widely used in cancer treatment, with transformative impacts on survival. They nonetheless carry a significant risk of toxicity in the form of immune-related adverse events (Ir...

    Authors: Abigail Gault, Linda Hogarth, Kristian C Williams, Alastair Greystoke, Neil Rajan, Ally Speight, Christopher A Lamb, Alison Bridgewood, Lisa-Jayne Brown-Schofield, Fiona Rayner, John D Isaacs, Jérémie Nsengimana, Christopher J Stewart, Amy E Anderson, Ruth Plummer and Arthur G Pratt
    Citation: BMC Cancer 2024 24:733
  38. Considering the age relevance of prostate cancer (PCa) and the involvement of the cGAS-STING pathway in aging and cancer, we aim to classify PCa into distinct molecular subtypes and identify key genes from the...

    Authors: Jie Yang, Zihan Xu, Weitao Zheng, Yifan Li, Qiang Wei and Lu Yang
    Citation: BMC Cancer 2024 24:732
  39. Oral cavity squamous cell carcinoma (OCSCC) is the most common pathological type in oral tumors. This study intends to construct a novel prognostic nomogram model based on China populations for these resectabl...

    Authors: Xue-Lian Xu, Jin-Hong Xu, Jia-Qi He, Yi-Hao Li and Hao Cheng
    Citation: BMC Cancer 2024 24:730
  40. Chondroitin sulfate proteoglycan 4 pseudogene 12 (CSPG4P12) has been implicated in the pathogenesis of various cancers. This study aimed to evaluate the association of the CSPG4P12 polymorphism with esophageal sq...

    Authors: Hongxue Xu, Zhenbang Yang, Wenqian Hu, Xianlei Zhou, Zhi Zhang and Xuemei Zhang
    Citation: BMC Cancer 2024 24:729
  41. Circular RNA (circRNAs) have been found to play major roles in the progression of colorectal cancer (CRC). However, the functions of circ_0008345 (transcribed by PTK2) in regulating CRC development remain unde...

    Authors: Chaofeng Hou, Jinbo Liu, Junwei Liu, Danjie Yao, Fang Liang, Congpeng Qin and Zhiyong Ma
    Citation: BMC Cancer 2024 24:728
  42. The Naples Prognostic Score (NPS), integrating inflammatory and nutritional biomarkers, has been reported to be associated with the prognosis of various malignancies, but there is no report on intrahepatic cho...

    Authors: Cheng-Fei Du, Zhen-Yu Gao, Zhu-Ding Xu, Zheng-Kang Fang, Zi-Chen Yu, Zhe-Jin Shi, Kai-Di Wang, Wen-Feng Lu, Xiao-Kun Huang, Lei Jin, Tian-Wei Fu, Guo-Liang Shen, Jun-Wei Liu, Cheng-Wu Zhang, Dong-Sheng Huang and Lei Liang
    Citation: BMC Cancer 2024 24:727
  43. Polysaccharopeptide (PSP) is a potential active component in traditional Chinese medicine because of its anticancer effects on a variety of cancer cells and as immune enhancers of the immune system. Previous s...

    Authors: Cuixiang Xu, Lijun Sun, Huxia Wang, Jingying Sun, Yangmeng Feng, Xingguang Wang and Zhangjun Song
    Citation: BMC Cancer 2024 24:726
  44. Tumor immune infiltration leads to poor prognosis of gastric cancer patients and seriously affects the life quality of gastric cancer patients. This study was based on bioinformatics to screen prognostic bioma...

    Authors: MeiHong Yu, Jingxuan Peng, Yanxu Lu, Sha Li and Ke Ding
    Citation: BMC Cancer 2024 24:724
  45. Among the 10% of pancreatic cancers that occur in a familial context, around a third carry a pathogenic variant in a cancer predisposition gene. Genetic studies of pancreatic cancer predisposition are limited ...

    Authors: Sofie Joris, Philippe Giron, Catharina Olsen, Sara Seneca, Alexander Gheldof, Shula Staessens, Rajendra Bahadur Shahi, Sylvia De Brakeleer, Erik Teugels, Jacques De Grève and Frederik J. Hes
    Citation: BMC Cancer 2024 24:723

Featured videos

View featured videos from across the BMC-series journals